Location:
Level 6, Seminar Room Wallace Wurth Building UNSW Australia Sydney NSW 2052
Open to
All
Contact for enquiries
Rata Joseph +61 (0)2 9385 0900 rjoseph@kirby.unsw.edu.au
The Kirby Institute is pleased to present:
Dr Jeff Jin - Senior Lecturer- HIV Epidemiology and Prevention Program-Kirby Institute & Dr Mary Poynten-Senior Lecturer- HIV Epidemiology Prevention Program- Kirby Institute
“The Study of the Prevention of Anal Cancer (SPANC): baseline findings and early longitudinal results”.
Please RSVP to rjoseph@kirby.unsw.edu.au for catering purposes by COB Friday 2nd September.
Lunch will be served at 12.30pm
Abstract:
The Study of the Prevention of Anal Cancer (SPANC) is a three-year prospective longitudinal study of the natural history of anal human papillomavirus (HPV) infection in 617 gay and bisexual men. Recruitment and 12 month visits are complete, and follow up will finish in early 2018.This presentation will highlight results from recent publications as well as unpublished findings on how HPV biomarkers may help improve anal cancer screening.
Bio:
Dr Jeff Jin is a senior lecturer and an infectious disease and cancer epidemiologist at the Kirby Institute, UNSW. He completed his PhD in 2006 on the epidemiology of sexually transmissible infections in gay men based on the Health in Men study. Dr Jin's research interests include the epidemiology of sexually transmitted infections and human papillomavirus related anal cancer, HIV risk and prevention, and the methodology in epidemiological studies. He currently leads a biomarker study as part of the Study of the Prevention of Anal Cancer (SPANC) aiming to improve anal cancer screening in high-risk populations. Dr Jin is also centrally involved with the other ongoing cohort studies, including the Opposites Attract and the Following Lives Undergoing Change (Flux) studies as a co-chief investigator.
Dr Mary Poynten is a Senior Lecturer and clinical epidemiologist and has worked at The Kirby Institute for the past eight years.Mary has been involved in the design and implementation of HIV prevention trials, both nationally and internationally. She completed her PhD on biomedical methods of HIV prevention in 2010. Her research interests include biomedical HIV prevention technologies, in particular post-exposure prophylaxis and their impact on HIV risk behaviour and also treatment modalities of anal dysplasia.
Mary is project leader of the Study of the Prevention of Anal Cancer (SPANC) investigating the natural history of anal dysplasia in gay men. She is currently involved in the implementation of the SPANC study, and is collaborating with international researchers on HPV seroprevalence, seroincidence and risk factors in HIV negative gay Australian men.